Purpose Pharmacokinetic considerations in patients who have undergone Roux-en-Y gastric bypass (RYGB) are explored. Summary The prevalence of obesity, especially morbid obesity, has dramatically ...

Evgen Pharma (GB:TCF) has released an update. TheraCryf, the clinical-stage drug development company, announced positive ...

However, the observed trends in the incidence of adverse events are fully consistent with the obtained differences in pharmacokinetic parameters: a total of six of 24 subjects reported ten adverse ...

Streamlining processes like trial site selection and FDA documentation can make a meaningful difference in development ...

CVN293's clinical safety and pharmacokinetic profile have also been deemed favourable. CVN293 targets KCNK13, a potassium two ...

“The pharmacokinetic data announced today combined with the previously announced pharmacodynamic data further highlight the RaniPill’s potential to serve as a novel delivery platform for ...

This study will involve approximately 75 patients and aims to gather safety and pharmacokinetic data that will inform the design of subsequent trials, indicating a promising path forward for the drug ...

SBS-1000 was shown to be safe and well tolerated in healthy volunteers in this Phase 1 Single Ascending Dose (SAD) studyNo ...

Preclinical research shows that these new compounds retain the therapeutic benefits of psilocybin but have better ...

Additionally, the Phase 1a clinical trial evaluated pharmacokinetic (PK) and pharmacodynamic (PD) measures of TX45 based on relaxin’s known ability to increase RPF in order to create an ...

Continued execution across all programs, including positive results up to nine months from APG777 Phase 1 trial that continue to support ...

An alternate dosing plan for the anti-amyloid drug donanemab (Kisunla) reduced the risk of brain edema and effusion but still ...